Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature

BACKGROUND: The effectiveness of sofosbuvir/ribavirin (SOF/RBV) combination therapy, which is one of the 1(st)-choice therapeutic options for patients with hepatitis C virus (HCV) genotype 2 (HCV-G2) in Japan according to the most recent version of the Japan Society of Hepatology guideline, for pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Ken, Yamazaki, Yuichi, Kobayashi, Takeshi, Takakusagi, Satoshi, Horiguchi, Norio, Kakizaki, Satoru, Andou, Masayasu, Matsuda, Yoshihiro, Uraoka, Toshio, Ohnishi, Hiroshi, Okamoto, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511930/
https://www.ncbi.nlm.nih.gov/pubmed/31123677
http://dx.doi.org/10.12998/wjcc.v7.i9.1043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511930/
https://www.ncbi.nlm.nih.gov/pubmed/31123677
http://dx.doi.org/10.12998/wjcc.v7.i9.1043

Ejemplares similares